BS-181 |
|
A3266-100 |
ApexBio |
100mg |
EUR 600 |
|
|
|
Description: Cell Cycle/Checkpoint|Cyclin-Dependent Kinases |
Bioss Antibodies Laboratories manufactures the bioss bs-1004rpe reagents distributed by Genprice. The Bioss Bs-1004Rpe reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Bioss Antibodies. Other Bioss products are available in stock. Specificity: Bioss Category: Bs-1004Rpe
BzNH-BS |
|
MedChemExpress |
Get quote |
Ask for price |
|
Description: BzNH-BS contains two different ligands, methyl-bestatin (MeBS) for cIAP1 and benzoyl-amide, which are connected by linkers. MeBS as a ligand for cellular inhibitor of apoptosis protein 1 (cIAP1) ubiquitin ligase[1]. |
Biotin-BS |
|
MedChemExpress |
Get quote |
Ask for price |
|
Description: Biotin-BS contains two different ligands, methyl-bestatin (MeBS) for cIAP1 and biotin, which are connected by linkers. MeBS as a ligand for cellular inhibitor of apoptosis protein 1 (cIAP1) ubiquitin ligase[1]. |
BS-181 |
|
MedChemExpress |
10mg |
EUR 660.18 |
|
Description: BS-181 is a potent and selective CDK7 inhibitor (IC50=21 nM) than Seliciclib (HY-30237). BS-181 is also against CDK2, CDK5 and CDK9 with IC50 values of 880, 3000 and 4200 nM, respectively (fails to block CDK1, 4 and 6). BS-181 inhibits a panel of cancer cells growth (IC50=11.5 μM-37.3 μM) and induces cell apoptosis. BS-181 has the potential for the research of cancer therapy[1][2]. |
BS-194 |
|
MedChemExpress |
10 mg |
EUR 238.1 |
|
Description: BS-194 is an orally active, selective and potent CDK inhibitor. BS-194 inhibits CDK2, CDK1, CDK5, CDK7, CDK9 (IC50s: 3, 30, 30, 250, and 90 nM respectively). BS-194 potently inhibits cancer cells proliferation. BS-194 can be used in the research of cancers like breast cancer, colon cancer[1]. |
Test Assays information
BS-194 |
|
MBS131829-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
BzNH-BS |
|
HY-111878 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: BzNH-BS contains two different ligands, methyl-bestatin (MeBS) for cIAP1 and benzoyl-amide, which are connected by linkers. MeBS as a ligand for cellular inhibitor of apoptosis protein 1 (cIAP1) ubiquitin ligase[1]. |
BS-181 |
|
HY-13266 |
MedChemExpress |
10mg |
EUR 660.18 |
|
Description: BS-181 is a potent and selective CDK7 inhibitor (IC50=21 nM) than Seliciclib (HY-30237). BS-181 is also against CDK2, CDK5 and CDK9 with IC50 values of 880, 3000 and 4200 nM, respectively (fails to block CDK1, 4 and 6). BS-181 inhibits a panel of cancer cells growth (IC50=11.5 μM-37.3 μM) and induces cell apoptosis. BS-181 has the potential for the research of cancer therapy[1][2]. |
BS-194 |
|
HY-14372 |
MedChemExpress |
10 mg |
EUR 238.1 |
|
Description: BS-194 is an orally active, selective and potent CDK inhibitor. BS-194 inhibits CDK2, CDK1, CDK5, CDK7, CDK9 (IC50s: 3, 30, 30, 250, and 90 nM respectively). BS-194 potently inhibits cancer cells proliferation. BS-194 can be used in the research of cancers like breast cancer, colon cancer[1]. |
